rs13306198
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000384.3(APOB):c.581C>T(p.Thr194Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0016 in 1,614,104 control chromosomes in the GnomAD database, including 48 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in UniProt.
Frequency
Consequence
NM_000384.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
APOB | ENST00000233242.5 | c.581C>T | p.Thr194Met | missense_variant | Exon 6 of 29 | 1 | NM_000384.3 | ENSP00000233242.1 | ||
APOB | ENST00000399256.4 | c.581C>T | p.Thr194Met | missense_variant | Exon 6 of 17 | 1 | ENSP00000382200.4 | |||
APOB | ENST00000673739.2 | n.427C>T | non_coding_transcript_exon_variant | Exon 5 of 25 | ENSP00000501110.2 | |||||
APOB | ENST00000673882.2 | n.427C>T | non_coding_transcript_exon_variant | Exon 5 of 23 | ENSP00000501253.2 |
Frequencies
GnomAD3 genomes AF: 0.00230 AC: 350AN: 152128Hom.: 9 Cov.: 32
GnomAD3 exomes AF: 0.00486 AC: 1221AN: 251406Hom.: 26 AF XY: 0.00439 AC XY: 596AN XY: 135872
GnomAD4 exome AF: 0.00152 AC: 2229AN: 1461858Hom.: 39 Cov.: 32 AF XY: 0.00149 AC XY: 1083AN XY: 727230
GnomAD4 genome AF: 0.00228 AC: 347AN: 152246Hom.: 9 Cov.: 32 AF XY: 0.00261 AC XY: 194AN XY: 74426
ClinVar
Submissions by phenotype
not provided Benign:4
This variant is associated with the following publications: (PMID: 33303402) -
- -
- -
- -
Familial hypercholesterolemia Benign:2
- -
- -
Hypercholesterolemia, autosomal dominant, type B;C4551990:Familial hypobetalipoproteinemia 1 Benign:1
- -
Hypercholesterolemia, autosomal dominant, type B Benign:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Hypercholesterolemia, familial, 1 Benign:1
- -
Familial hypobetalipoproteinemia 1 Benign:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
Cardiovascular phenotype Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at